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Some  central  effects  of  cocaine  administration  seem  to be  related  to  angiotensin  II  (Ang  II)  or  its  metabo-
lites.  Nonetheless,  it is  still  an  open  question  whether  or  not  the levels  of  angiotensin  I-converting  enzyme
(ACE),  the  main  Ang  II  generating  enzyme,  are  modiﬁed  by  cocaine  administration.  To  evaluate  the  effect
of acute  and subchronic  cocaine  administration  on  ACE  activity  and  mRNA  expression,  male  rats  were
randomly  assigned  to saline  or cocaine  group.  Acute  and  subchronic  cocaine  administration  induced  a
signiﬁcant  increase  in ACE  activity  and  mRNA  expression  in the frontal  cortex  and  striatum  but  not  in theeywords:
ngiotensin I-converting enzyme (ACE)
ngiotensin II (Ang II)
entral nervous system
ocaine
rontal cortex
triatum
hippocampus.  These  results  suggest  that  some  of  the  Ang  II related  effects  of  cocaine  upon  the  central
nervous  system  can  be mediated  by  changes  on  the expression  and  activity  of  ACE  in  the  striatum  and
frontal  cortex.
Crown Copyright ©  2011 Published by Elsevier Ireland Ltd. All rights reserved.. Introduction
Cocaine is one of the most commonly abused illicit drugs [18].
n 2007, the estimated worldwide total number of people, aged
5–64 years old, who used cocaine was 15.6–20.8 million (0.4–0.5%
f those in this age group) [40].
It is well-documented that systemic acute cocaine adminis-
ration induces autonomic responses mediated by the central
ucleus of the amygdala (CeA) [39]. Peripheric injection of cocaine
7 mg/kg) induces signiﬁcant alterations in a number of behaviors,
uch as stereotyped, locomotor, rearing and anxiety-like behaviors
5]. In addition, it has been shown that repeated administration of
ocaine at a similar dose range (10 mg/kg for 5 days) can induce
ocomotor sensitization in rodents [15], an animal model of addic-
ion [21,37].  Sakoori and Murphy using a 7.5 mg/kg dose showed
ocaine-associated place preference [34]. Moreover, Reichel et al.
emonstrated the effects of low doses of cocaine (5–7.5 mg/kg)
n a modiﬁed variant of the place conditioning task, referred as a
∗ Corresponding author at: Departamento de Psicobiologia, Universidade Federal
e  São Paulo, Rua Napoleão de Barros, 925, 04024-002, São Paulo, SP, Brazil.
el.: +55 112149 0155x189; fax: +55 112149 0155.
E-mail address: jchagas1@gmail.com (J.R. Chagas).
304-3940/$ – see front matter Crown Copyright ©  2011 Published by Elsevier Ireland Lt
oi:10.1016/j.neulet.2011.10.054‘reference – conditioning’ procedure that compared two potentially
rewarding stimuli (high vs. low dose) [31]. Many of these activities
are related to dopamine re-uptake blockade. However, the speciﬁc
molecular mechanisms involved or whether this activation is due
to the direct effects of cocaine on dopaminergic neurons and/or
actions on other neuromodulatory systems are still under study
[11].
Dopamine release in the striatum of the rat can be directly
affected by angiotensin II (Ang II) [13,28] or through an Ang II
metabolite like angiotensin IV (Ang IV) [8,9,38]. Ang II, increases
corticotropin releasing factor (CRF) release [1] an effect also
induced by cocaine withdrawal [12]. Of note, angiotensin I-
converting enzyme (ACE, EC 3.4.15.1), the main Ang II generating
enzyme, is an essential part of the renin-angiotensin system (RAS)
present in the brain. A recent review emphasizes the importance
and possible implications of the complete RAS in the brain, where
it acts to regulate a number of physiological processes (e.g. cardio-
vascular maintenance, memory, ﬂuid intake, energy balance) [3].
Angiotensin I-converting enzyme inhibitors (ACEi) are ligands that
form a complex with Zn2+ at the active site of ACE. ACEi are effective
in reducing blood pressure in hypertensive individuals as they block
the conversion of angiotensin I to Ang II and reduce the degrada-
tion of bradykinin. As pointed out by Margolin et al. ACEi are able
to increase dopamine release in the striatum, an effect probably
d. All rights reserved.
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ediated by the opioid system. As they indirectly could block CRF
elease and directly block Ang II production, ACEi have been sug-
ested to be used in the treatment of cocaine abuse [27]. Moreover,
t was observed that chronic administration of ACEi increased the
urnover of dopamine in the striatum of rats [20].
It is still an open question whether or not the levels of ACE
re modiﬁed by cocaine administration, potentially leading to an
ncrease in the generation of Ang II and its metabolites. In an
ttempt to answer this question, following acute and subchronic
ocaine administration in rats, we evaluated ACE activity and mRNA
xpression in different areas, in the central nervous system, known
o have increased extracellular dopamine under Ang II effect or to
e linked to motor activity.
. Materials and methods
Male Wistar rats (3 months of age) were obtained from CEDEME
 Universidade Federal de São Paulo (UNIFESP). The animals
ere housed in a room maintained at 22 ◦C in 12:12 h light–dark
ycle (lights on at 07:00 a.m. and off at 19:00 h) inside standard
olypropylene cages. All procedures used in the present study com-
lied with the Guide for the Care and Use of Laboratory Animals
19]. The experimental protocol was approved by the Ethical Com-
ittee of UNIFESP (#1001/09).
Cocaine hydrochloride (Sigma Chemical Co., St. Louis, MO,  USA)
as freshly dissolved in saline solution. Intraperitoneal (ip) injec-
ions were given at a constant volume of 1 mL/kg. Naive subjects
ere randomly assigned to 2 treatment groups, saline and cocaine
dministration. A single dose of cocaine 7 mg/kg or saline was
dministered intraperitoneally to the rats at 7:30 a.m. only 1 day
acute) or during 5 days (subchronic) at the same time. Six hours
fter the single dose (acute) or 6 h after the ﬁfth dose adminis-
ration (subchronic), the animals were decapitated with minimum
iscomfort. Two additional groups (withdrawal and the respective
ontrol) received ip daily injections of cocaine (7 mg/kg) or saline
or 5 consecutive days and were euthanized 24 h after the ﬁfth
dministration. The dose of 7 mg/kg was chosen on the basis of
revious studies [4,5].
After decapitation the frontal cortex, striatum and hippocampus
ere rapidly dissected for protein or total RNA extraction (Tri-
ol, Invitrogen Life Technologies, Carlsbad, CA, USA). For protein
xtraction, tissues were homogenized in a buffer containing 50 mM
ris–HCl, pH 7.4, NaCl 100 mM and 0.1% Triton. Homogenates were
entrifuged at 1000 g for 15 min  and the supernatant was  frozen at
20 ◦C. The protein contents of the samples were measured by the
radford method [7] using bovine serum albumin as a standard.
ACE activity on tissue extracts was determined using the FRET
eptide Abz-FRK(Dnp)P-OH (10 M)  as previously described [10].
he reactions were continuously followed in a Gemini XS ﬂuorime-
er (Molecular Devices Company, Sunnyvale, CA, USA) measuring
he ﬂuorescence at ex = 320 nm and em = 420 nm.  Measurements
ere performed in duplicate and ACE activity values were reported
s nanomolar of substrate hydrolyzed per minute per milligram of
rotein (nM min−1 mg−1). In separate control experiments, cocaine
oncentrations up to 1 mM were added to incubation in order to
erify the possibility of a direct action of cocaine on enzyme activity.
ACE, -actin and GAPDH mRNA expression in tissue were
ssessed by SYBR Green real-time PCR using 10 ng of total
DNA, SYBR Green Universal Master Mix  (Applied Biosys-
ems, Carlsbad, CA, USA), and the following set of primers
ndependently: ACE (5′CGGTTTTCATGAGGCTATTGG3′ and
′TCGTAGCCACTGCCCTCACT3′ GenBank accession number
M 012544), -actin (5′AGGCCAACCGTGAAAAGATG3′ and
′CCAGAGGCATACAGGGACAAC3′ GenBank accession number
M 031144.2) and GAPDH (5′TGCCCCCATGTTTGTGATG3′ ande Letters 506 (2012) 84– 88 85
5′GCTGACAATCTTGAGGGAGTTGT3′ GenBank accession number
NM 017008) [26]. ACE, -actin and GAPDH mRNA expressions
were obtained from the cycle threshold (Ct) associated with the
exponential growth of the PCR products. Quantitative values for
ACE mRNA expression were obtained by the parameter 2−Ct, in
which Ct represents the subtraction of the -actin or the GAPDH
Ct values from the ACE Ct values.
Studentıˇs-t  test for independent samples by group was used to
analyze the data. Values are expressed as the ± standard error of
mean (SEM). p < 0.05 was considered statistically signiﬁcant.
3. Results
Fig. 1 shows that acute cocaine treatment signiﬁcantly increased
ACE gene expression in the rat cortex (t: −2.99; df: 12; p < 0.01)
and striatum (t: −4.48; df: 12; p < 0.001) compared to saline treat-
ment. Similar alterations were seen in ACE mRNA after subchronic
cocaine treatment (frontal cortex t: −2,36; df: 10; p < 0.04 and stria-
tum t: −3.24; df: 10; p < 0.009). There were signiﬁcant differences
among groups in ACE expression relative to endogen controls -
actin or GAPDH (data not shown).ACE activity values are shown in
Fig. 2. Acute and subchronic administration induced a signiﬁcant
increase in ACE activity in the frontal cortex (acute t: −10.24; df:
10; p < 0.001 and subchronic t: −4.69, df: 11; p < 0.001/Fig. 2A and
D) and striatum (acute t: −3.80; df: 11; p < 0.003 and subchronic t:
−3.53; df: 11; p < 0.005/Fig. 2B and E). In a separate control, there
was  no effect of cocaine alone, added up to 1 mM in the incubation
medium, on ACE activity (data not shown). However, no signiﬁ-
cant difference was observed in ACE activity after 24 h withdrawal
of repeated cocaine administration (frontal cortex t: 0.91; df: 12;
p = 0.37; striatum t: 0.11; df: 13; p = 0.91 and hippocampus t: −1.08;
df: 12; p = 0.3; Fig. 2G–I). In a separate control, there was no effect
of cocaine alone, added up to 1 mM in the incubation medium, on
ACE activity (data not shown).
No signiﬁcant changes were obtained either for ACE activity
(acute t: −1.54; df: 11; p = 0.15 and subchronic t: 0.85; df: 11;
p = 0.41) or mRNA (acute t: −1.82; df: 12; p = 0.09 and subchronic t:
−1.78; df: 10; p = 0.10) in tissue extracts from the hippocampus.
4. Discussion
The data reported in this study show that cocaine administra-
tion in rats exerts distinct effects upon the central nervous system.
The results show that acute and subchronic cocaine administration
induced a selective increase in relative mRNA in the frontal cor-
tex and striatum. Moreover, acute cocaine produced a 3-fold and
2-fold increase of ACE activity in the frontal cortex and striatum,
respectively. After subchronic cocaine administration, those differ-
ences remained signiﬁcative (frontal cortex 1.8-fold and striatum
1.6-fold, Fig. 2A and B). No signiﬁcant difference was  observed in
ACE activity after 24 h withdrawal of repeated cocaine adminis-
tration in frontal cortex and striatum. In addition, no signiﬁcant
differences were observed in either condition in the hippocampus.
Regarding our data, there are many evidences that Ang II or its
metabolites, like Ang IV, can modulate dopamine release in the
striatum of the rat [8,9,13,28,38].  The found rise in ACE expression
and activity probably implies in the generation of more Ang II and
its metabolites, leading to the known involvement of angiotensin
receptors in cocaine effects. It is known that cocaine administration
induces increased extracellular dopamine in the striatum and the
activation of speciﬁc intracellular pathways. These changes include
the regulation of gene and protein expression that occur in speciﬁc
areas of the brain and are related to changes in neural plasticity in
response to the effects of conditioning and sensitization [6,22,30].
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Aig. 1. Plot representation of ACE mRNA relative amount after (A) acute and subchr
p < 0.02 and (B) *p < 0.04, striatum relative to -actin (A) *p < 0.001 and (B) *p < 0.007
s  the mean ± standard error of mean (SEM).
Both cocaine regimens (acute and repeated) produced the same
evel of response not only at the ACE activity but also at the mRNA
xpression in the striatum and in the frontal cortex. In the case of
he repeated regimen, it can also be interpreted as a response to the
ast cocaine injection and not to the repeated treatment. In line with
he latter possibility, when another time point further away from
he injection (i.e. 24 h) was considered in order to measure estab-
ished long term effects, no effects on ACE activity was observed
n either brain area. Both, striatum and the frontal cortex, seem to
e related to the behavioral sensitization phenomenon and to drug
ddiction [17,23,25];  Given that the dose range and duration of
ocaine repeated administration used here are effective at produc-
ng behavioral sensitization [15], one would expect that the effects
f repeated cocaine on ACE activity and mRNA expression would
lso sensitize after repeated administration. Thus it is important
o highlight here that any possible implication of the ﬁndings pre-
ented in cocaine behavioral effects would need further behavioral
xperiments to be corroborated.
Although not yet demonstrated in nervous tissues, beyond its
bility to form Ang II and process many active peptides, ACE also
cts as a signaling molecule by itself at the cell membrane, trig-
ering intracellular phosphorylation events [14] and calcium entry
16]. These recent ﬁndings indicate that, potentially, an increase
n ACE expression could not only affect Ang II formation, activating
ngiotensin receptors but also increase a possible signaling through
CE itself.B) cocaine (7 mg/kg, i.p.) administration in the frontal cortex relative to -actin (A)
hippocampus relative to -actin (A) *p = 0.09 and (B) *p = 0.19. Values are expressed
In  vivo, ACE is able to hydrolyze bradykinin and substance P
[36]. Opioid peptides, corticotrophin [33,35], hemopressin [32] and
amyloid -protein [29] were also shown to be in vitro ACE sub-
strates. Opioid peptides, like endorphins and enkephalins, are ACE
substrates whose dynamics are probably altered by changes in ACE
activity with consequences in pain perception [2].  Moreover, mod-
iﬁcations on ACE activity can potentially result in alterations in the
metabolism of these neuropeptides and in vivo could be related
to cocaine addiction. ACE inhibitors have been suggested to be
used for treating cocaine addiction since they were able to stim-
ulate the release of dopamine in the CNS [20]. Further studies also
point to other of ACE inhibitors in the CNS that may  have potential
applicability for the treatment of cocaine addiction [24,27].
Our results suggest the involvement of brain ACE in the Ang
II related effects of cocaine administration. Generation of Ang II
and processing of opioid peptides could directly affect dopamine
dynamics in regions where ACE increase is induced by cocaine.
Ang IV, an Ang II metabolite, participates in memory and learning
through a mechanism involving D1–D4 dopamine receptors and
inhibition of the Insulin Regulated Aminopeptidase (IRAP) [8].  Ang
IV could also be involved in the mechanisms of cocaine addiction
adding on the memory consolidation of its rewarding effects. Fur-
ther studies will allow us to specify the areas of tissues where the
presented changes in ACE take place and evaluate the effect of these
changes on the levels and activity of involved neuropeptides and
receptors in vivo.
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Fig. 2. Plot representation for ACE speciﬁc proteolytic activity in the control and in the acute cocaine treated animals in: (A) frontal cortex (*p < 0.001), (B) striatum (*p < 0.003)
and  (C) hippocampus (p = 0.15), subchronic cocaine treated animals in: (D) frontal cortex (*p < 0.001), (E) striatum (*p < 0.005) and (F) hippocampus (p = 0.41) and after 24 h
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